202 related articles for article (PubMed ID: 10893309)
21. Thyroid hormone receptor does not heterodimerize with the vitamin D receptor but represses vitamin D receptor-mediated transactivation.
Raval-Pandya M; Freedman LP; Li H; Christakos S
Mol Endocrinol; 1998 Sep; 12(9):1367-79. PubMed ID: 9731705
[TBL] [Abstract][Full Text] [Related]
22. Ligand-specific structural changes in the vitamin D receptor in solution.
Singarapu KK; Zhu J; Tonelli M; Rao H; Assadi-Porter FM; Westler WM; DeLuca HF; Markley JL
Biochemistry; 2011 Dec; 50(51):11025-33. PubMed ID: 22112050
[TBL] [Abstract][Full Text] [Related]
23. Characterization of five 19-nor-analogs of 1alpha,25(OH)2-Vitamin D3 with 20-cyclopropyl-modified side-chains: implications for ligand binding and calcemic properties.
Olivera CJ; Bula CM; Bishop JE; Adorini L; Manchand P; Uskokovic MR; Norman AW
J Steroid Biochem Mol Biol; 2004 May; 89-90(1-5):99-106. PubMed ID: 15225754
[TBL] [Abstract][Full Text] [Related]
24. Enhancement of VDR-mediated transcription by phosphorylation: correlation with increased interaction between the VDR and DRIP205, a subunit of the VDR-interacting protein coactivator complex.
Barletta F; Freedman LP; Christakos S
Mol Endocrinol; 2002 Feb; 16(2):301-14. PubMed ID: 11818502
[TBL] [Abstract][Full Text] [Related]
25. The vitamin D receptor, Runx2, and the Notch signaling pathway cooperate in the transcriptional regulation of osteopontin.
Shen Q; Christakos S
J Biol Chem; 2005 Dec; 280(49):40589-98. PubMed ID: 16195230
[TBL] [Abstract][Full Text] [Related]
26. Biological activity of CD-ring modified 1alpha,25-dihydroxyvitamin D analogues: C-ring and five-membered D-ring analogues.
Verstuyf A; Verlinden L; van Etten E; Shi L; Wu Y; D'Halleweyn C; Van Haver D; Zhu GD; Chen YJ; Zhou X; Haussler MR; De Clercq P; Vandewalle M; Van Baelen H; Mathieu C; Bouillon R
J Bone Miner Res; 2000 Feb; 15(2):237-52. PubMed ID: 10703925
[TBL] [Abstract][Full Text] [Related]
27. A 20-epi side chain restores growth-regulatory and transcriptional activities of an A ring-modified hybrid analog of 1 alpha, 25-dihydroxyvitamin D3 without increasing its affinity to the vitamin D receptor.
Peleg S; Liu YY; Reddy S; Horst RL; White MC; Posner GH
J Cell Biochem; 1996 Nov; 63(2):149-61. PubMed ID: 8913867
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of 1,25-dihydroxyvitamin D3 stimulated osteocalcin gene transcription by tumor necrosis factor-alpha: structural determinants within the vitamin D response element.
Kuno H; Kurian SM; Hendy GN; White J; deLuca HF; Evans CO; Nanes MS
Endocrinology; 1994 Jun; 134(6):2524-31. PubMed ID: 8194478
[TBL] [Abstract][Full Text] [Related]
29. A new class of vitamin D analogues that induce structural rearrangement of the ligand-binding pocket of the receptor.
Inaba Y; Yoshimoto N; Sakamaki Y; Nakabayashi M; Ikura T; Tamamura H; Ito N; Shimizu M; Yamamoto K
J Med Chem; 2009 Mar; 52(5):1438-49. PubMed ID: 19193059
[TBL] [Abstract][Full Text] [Related]
30. Molecular basis of the selective activity of vitamin D analogues.
Carlberg C
J Cell Biochem; 2003 Feb; 88(2):274-81. PubMed ID: 12520526
[TBL] [Abstract][Full Text] [Related]
31. Novel Gemini analogs of 1alpha,25-dihydroxyvitamin D(3) with enhanced transcriptional activity.
Weyts FA; Dhawan P; Zhang X; Bishop JE; Uskokovic MR; Ji Y; Studzinski GP; Norman AW; Christakos S
Biochem Pharmacol; 2004 Apr; 67(7):1327-36. PubMed ID: 15013848
[TBL] [Abstract][Full Text] [Related]
32. Molecular and functional comparison of 1,25-dihydroxyvitamin D(3) and the novel vitamin D receptor ligand, lithocholic acid, in activating transcription of cytochrome P450 3A4.
Jurutka PW; Thompson PD; Whitfield GK; Eichhorst KR; Hall N; Dominguez CE; Hsieh JC; Haussler CA; Haussler MR
J Cell Biochem; 2005 Apr; 94(5):917-43. PubMed ID: 15578590
[TBL] [Abstract][Full Text] [Related]
33. Fine tuning of agonistic/antagonistic activity for vitamin D receptor by 22-alkyl chain length of ligands: 22S-Hexyl compound unexpectedly restored agonistic activity.
Anami Y; Sakamaki Y; Itoh T; Inaba Y; Nakabayashi M; Ikura T; Ito N; Yamamoto K
Bioorg Med Chem; 2015 Nov; 23(22):7274-81. PubMed ID: 26515040
[TBL] [Abstract][Full Text] [Related]
34. Vitamin D receptor agonists specifically modulate the volume of the ligand-binding pocket.
Molnár F; Peräkylä M; Carlberg C
J Biol Chem; 2006 Apr; 281(15):10516-26. PubMed ID: 16478719
[TBL] [Abstract][Full Text] [Related]
35. Adaptability of the Vitamin D nuclear receptor to the synthetic ligand Gemini: remodelling the LBP with one side chain rotation.
Ciesielski F; Rochel N; Moras D
J Steroid Biochem Mol Biol; 2007 Mar; 103(3-5):235-42. PubMed ID: 17218092
[TBL] [Abstract][Full Text] [Related]
36. Vitamin D receptor (VDR)-mediated actions of 1α,25(OH)₂vitamin D₃: genomic and non-genomic mechanisms.
Haussler MR; Jurutka PW; Mizwicki M; Norman AW
Best Pract Res Clin Endocrinol Metab; 2011 Aug; 25(4):543-59. PubMed ID: 21872797
[TBL] [Abstract][Full Text] [Related]
37. Applications of the Vitamin D sterol-Vitamin D receptor (VDR) conformational ensemble model.
Mizwicki MT; Bishop JE; Norman AW
Steroids; 2005; 70(5-7):464-71. PubMed ID: 15862832
[TBL] [Abstract][Full Text] [Related]
38. Novel ring A stereoisomers of 2-methyl-1alpha,25-dihydroxyvitamin D(3) and 2-methyl-20-epi-1alpha,25-dihydroxyvitamin D(3): transactivation of target genes and modulation of differentiation in human promyelocytic leukemia (HL-60) cells.
Nakagawa K; Kurobe M; Ozono K; Konno K; Fujishima T; Takayama H; Okano T
Biochem Pharmacol; 2000 Mar; 59(6):691-702. PubMed ID: 10677586
[TBL] [Abstract][Full Text] [Related]
39. An analog of 1alpha,25-dihydroxy-19-norvitamin D3 with the 1alpha-hydroxy group fixed in the axial position lacks biological activity in vitro.
Sicinski RR; Glebocka A; Plum LA; DeLuca HF
J Steroid Biochem Mol Biol; 2007 Mar; 103(3-5):293-7. PubMed ID: 17223547
[TBL] [Abstract][Full Text] [Related]
40. New derivative of 1alpha,25-dihydroxy-19-norvitamin D3 with 3'-alkoxypropylidene moiety at C-2: synthesis, biological activity and conformational analysis.
Glebocka A; Sicinski RR; DeLuca HF
J Steroid Biochem Mol Biol; 2004 May; 89-90(1-5):25-30. PubMed ID: 15225741
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]